Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 91 - 100 of 299 items for :

  • "Hyperthyroidism" x
Clear All
David Shaki Pediatric Endocrinology Unit, Saban Pediatric Medical Center for Israel, Beer Sheva, Israel
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by David Shaki in
Google Scholar
PubMed Close
,
Marina Eskin-Schwartz Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by Marina Eskin-Schwartz in
Google Scholar
PubMed Close
,
Noam Hadar Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by Noam Hadar in
Google Scholar
PubMed Close
,
Emily Bosin Endocrinology Lab, Soroka University Medical Center, Beer Sheva, Israel

Search for other papers by Emily Bosin in
Google Scholar
PubMed Close
,
Lior Carmon Pediatric Endocrinology Unit, Saban Pediatric Medical Center for Israel, Beer Sheva, Israel
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by Lior Carmon in
Google Scholar
PubMed Close
,
Samuel Refetoff Departments of Medicine and Pediatrics and the Committee on Genetics, The University of Chicago, Chicago, Illinois, USA

Search for other papers by Samuel Refetoff in
Google Scholar
PubMed Close
,
Eli Hershkovitz Pediatric Endocrinology Unit, Saban Pediatric Medical Center for Israel, Beer Sheva, Israel
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by Eli Hershkovitz in
Google Scholar
PubMed Close
,
Ohad S Birk Genetics Institute at Soroka University Medical Center and the Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases, at the Faculty of Health Sciences and National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by Ohad S Birk in
Google Scholar
PubMed Close
, and
Alon Haim Pediatric Endocrinology Unit, Saban Pediatric Medical Center for Israel, Beer Sheva, Israel
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel

Search for other papers by Alon Haim in
Google Scholar
PubMed Close

the R75G TSHB variant cannot be distinguished from patients with subclinical hyperthyroidism, defined biochemically as having normal serum free thyroxine (T4) and triiodothyronine (T3) concentrations in the presence of a subnormal serum level of TSH

Article Type:
Research Article
Collections:
Hypothalamus-pituitary-thyroid axis
DOI:
https://doi.org/10.1530/ETJ-21-0072
Volume/Issue:
Volume 11: Issue 1
Open access
Irene Campi Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy

Search for other papers by Irene Campi in
Google Scholar
PubMed Close
,
Maura Agostini Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom

Search for other papers by Maura Agostini in
Google Scholar
PubMed Close
,
Federica Marelli Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy

Search for other papers by Federica Marelli in
Google Scholar
PubMed Close
,
Tiziana de Filippis Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy

Search for other papers by Tiziana de Filippis in
Google Scholar
PubMed Close
,
Beatriz Romartinez-Alonso Department of Molecular and Cell Biology, Leicester Institute of Structural and Chemical Biology, University of Leicester, Leicester, United Kingdom

Search for other papers by Beatriz Romartinez-Alonso in
Google Scholar
PubMed Close
,
Odelia Rajanayagam Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom

Search for other papers by Odelia Rajanayagam in
Google Scholar
PubMed Close
,
Giuditta Rurale Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy

Search for other papers by Giuditta Rurale in
Google Scholar
PubMed Close
,
Ilaria Gentile Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Search for other papers by Ilaria Gentile in
Google Scholar
PubMed Close
,
Federica Spagnolo Unit of Endocrinology, University Hospital “G. Martino”, Messina, Italy

Search for other papers by Federica Spagnolo in
Google Scholar
PubMed Close
,
Massimiliano Andreasi Laboratorio Analisi Cliniche, Centro di Ricerche e Tecnologie Biomediche, IRCCS Istituto Auxologico Italiano, Cusano Milanino, Italy

Search for other papers by Massimiliano Andreasi in
Google Scholar
PubMed Close
,
Francesco Ferraù Unit of Endocrinology, University Hospital “G. Martino”, Messina, Italy
Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy

Search for other papers by Francesco Ferraù in
Google Scholar
PubMed Close
,
Salvatore Cannavò Unit of Endocrinology, University Hospital “G. Martino”, Messina, Italy
Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy

Search for other papers by Salvatore Cannavò in
Google Scholar
PubMed Close
,
Laura Fugazzola Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy

Search for other papers by Laura Fugazzola in
Google Scholar
PubMed Close
,
Krishna V. Chatterjee Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom

Search for other papers by Krishna V. Chatterjee in
Google Scholar
PubMed Close
, and
Luca Persani Division of Endocrine and Metabolic Diseases and Laboratory of Endocrine and Metabolic Research, Istituto Auxologico Italiano, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Search for other papers by Luca Persani in
Google Scholar
PubMed Close

residues 234–264, 316–347, and 426–454 of thyroid hormone receptor beta. Spurious hyperthyroxinemia due to thyroid function assay interferences is a frequent pitfall in the differential diagnosis of central hyperthyroidism. Novel Insights

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000519748
Volume/Issue:
Volume 10: Issue 6
Free access
Stan R Ursem Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands

Search for other papers by Stan R Ursem in
Google Scholar
PubMed Close
,
Anita Boelen Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development, Amsterdam, The Netherlands

Search for other papers by Anita Boelen in
Google Scholar
PubMed Close
,
Jacquelien J Hillebrand Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands

Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed Close
,
Wendy P J den Elzen Department of Laboratory Medicine, Laboratory Specialized Diagnostics & Research, Amsterdam UMC location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Public Health, Amsterdam, The Netherlands

Search for other papers by Wendy P J den Elzen in
Google Scholar
PubMed Close
, and
Annemieke C Heijboer Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location University of Amsterdam, Meibergdreef, Amsterdam, The Netherlands
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam Reproduction & Development, Amsterdam, The Netherlands
Department of Laboratory Medicine, Endocrine Laboratory, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan, Amsterdam, The Netherlands

Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed Close

symptoms can be subtle and also for monitoring therapy in hypo- or hyperthyroidism and assessing suppressive therapy in patients with thyroid cancer. Unfortunately, TSH assays are poorly standardized to date. The IFCC Working Group on Standardization of

Article Type:
Research Article
Collections:
Thyroid function tests
DOI:
https://doi.org/10.1530/ETJ-23-0123
Volume/Issue:
Volume 12: Issue 5
Open access
Hippolyte Dupuis Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Hippolyte Dupuis in
Google Scholar
PubMed Close
,
Emilie Merlen Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France

Search for other papers by Emilie Merlen in
Google Scholar
PubMed Close
,
Arnaud Jannin Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Arnaud Jannin in
Google Scholar
PubMed Close
,
Philippe Jamme University of Lille, Lille, France
Department of Dermatology, Lille University Hospital, Lille, France

Search for other papers by Philippe Jamme in
Google Scholar
PubMed Close
,
Alexandre Fagart Department of Nuclear Medicine, Valenciennes Hospital Center, Valenciennes, France

Search for other papers by Alexandre Fagart in
Google Scholar
PubMed Close
,
Marie-Christine Vantyghem Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France
University of Lille, Lille, France

Search for other papers by Marie-Christine Vantyghem in
Google Scholar
PubMed Close
, and
Miriam Ladsous Department of Endocrinology, Diabetology and Metabolism, Huriez Hospital, Lille University Hospital, Lille, France

Search for other papers by Miriam Ladsous in
Google Scholar
PubMed Close

-old male who was incidentally found to have mild hyperthyroidism with low TSH (0.043 mU/L (0.4–3.6)) and slightly increased free thyroxine (FT4) (14.6 pmol/L (8.4–14.4)) ( Fig. 1 ). Free triiodothyronine (FT3) was not measured. The patient had received an

Article Type:
Case Report
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-22-0024
Volume/Issue:
Volume 11: Issue 4
Open access
Markus Eszlinger Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada, and Institute of Pathology, University Hospital Halle, Halle, Germany

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed Close
,
Alexandra Stephenson Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed Close
,
Shideh Mirhadi Program in Cell Biology, Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada

Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed Close
,
Konrad Patyra Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland

Search for other papers by Konrad Patyra in
Google Scholar
PubMed Close
,
Michael F Moran Program in Cell Biology, Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada

Search for other papers by Michael F Moran in
Google Scholar
PubMed Close
,
Moosa Khalil Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Moosa Khalil in
Google Scholar
PubMed Close
,
Jukka Kero Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Department of Pediatrics, Turku University Hospital, Turku, Finland

Search for other papers by Jukka Kero in
Google Scholar
PubMed Close
, and
Ralf Paschke Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada, and Institute of Pathology, University Hospital Halle, Halle, Germany
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed Close

Introduction Nonautoimmune hyperthyroidism (NAH) is caused by a constitutively activating thyroid stimulating hormone receptor (TSHR) germline mutation. Germline mutations in TSHR lead to sporadic and familial NAH (SNAH, FNAH) whereas somatic

Article Type:
Research Article
Collections:
Thyroid cancer - basic and translational
DOI:
https://doi.org/10.1530/ETJ-23-0049
Volume/Issue:
Volume 12: Issue 6
Open access
Jingyue Chen Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China

Search for other papers by Jingyue Chen in
Google Scholar
PubMed Close
,
Chenyan Li Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China

Search for other papers by Chenyan Li in
Google Scholar
PubMed Close
,
Weiping Teng Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China

Search for other papers by Weiping Teng in
Google Scholar
PubMed Close
,
Zhongyan Shan Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China

Search for other papers by Zhongyan Shan in
Google Scholar
PubMed Close
,
Jun Jin Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Jun Jin in
Google Scholar
PubMed Close
,
Yining Wei Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Yining Wei in
Google Scholar
PubMed Close
,
Jing Sun Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Jing Sun in
Google Scholar
PubMed Close
,
Yushu Li Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China

Search for other papers by Yushu Li in
Google Scholar
PubMed Close
, and
Huifang Zhou Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Huifang Zhou in
Google Scholar
PubMed Close

Response options GD patients with mild active TED and a CAS of three points present a management challenge. Do you have a preference regarding first-line treatment for hyperthyroidism? Anti-thyroid drugs, radioiodine, radioiodine plus oral

Article Type:
Research Article
Collections:
Thyroid autoimmunity
DOI:
https://doi.org/10.1530/ETJ-23-0269
Volume/Issue:
Volume 13: Issue 3
Open access
Eddy Rijntjes Institut für Experimentelle Endokrinologie, Charité-Universtätsmedizin Berlin, Berlin, Germany

Search for other papers by Eddy Rijntjes in
Google Scholar
PubMed Close
,
Philip Moritz Scholz Institut für Experimentelle Endokrinologie, Charité-Universtätsmedizin Berlin, Berlin, Germany

Search for other papers by Philip Moritz Scholz in
Google Scholar
PubMed Close
,
Govindasamy Mugesh Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore, India

Search for other papers by Govindasamy Mugesh in
Google Scholar
PubMed Close
, and
Josef Köhrle Institut für Experimentelle Endokrinologie, Charité-Universtätsmedizin Berlin, Berlin, Germany

Search for other papers by Josef Köhrle in
Google Scholar
PubMed Close

Introduction The thioamide compounds 6- n -propyl-2-thiouracil (PTU), methimazole (MMI) and carbimazole represent widely used anti-thyroid therapeutic drugs in the treatment of hyperthyroidism [ 1 ]. Their main pharmacological target is the

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000355288
Volume/Issue:
Volume 2: Issue 4
Free access
Massimo Giusti Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Massimo Giusti in
Google Scholar
PubMed Close
,
Stefano Gay Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Stefano Gay in
Google Scholar
PubMed Close
,
Lucia Conte Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Lucia Conte in
Google Scholar
PubMed Close
,
Francesca Cecoli Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy

Search for other papers by Francesca Cecoli in
Google Scholar
PubMed Close
,
Lorenzo Mortara Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy

Search for other papers by Lorenzo Mortara in
Google Scholar
PubMed Close
,
Lara Vera Endocrine Unit, San Martino Polyclinic Hospital, Genoa, Italy

Search for other papers by Lara Vera in
Google Scholar
PubMed Close
, and
Eleonora Monti Department of Internal Medicine, University of Genoa, Genoa, Italy

Search for other papers by Eleonora Monti in
Google Scholar
PubMed Close

measured by means of the Italian version of ThyPRO. This questionnaire consists of 85 questions, grouped into 13 multi-item scales. The ThyPRO scales concern the following aspects: goiter symptoms, hyperthyroid symptoms, hypothyroid symptoms, eye symptoms

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000501201
Volume/Issue:
Volume 9: Issue 5
Free access
Annabel S. Zaat Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by Annabel S. Zaat in
Google Scholar
PubMed Close
,
Joep P.M. Derikx Department of Pediatric Surgery, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam and Vrije Universiteit, Amsterdam, The Netherlands

Search for other papers by Joep P.M. Derikx in
Google Scholar
PubMed Close
,
Nitash Zwaveling-Soonawala Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed Close
,
A.S. Paul van Trotsenburg Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by A.S. Paul van Trotsenburg in
Google Scholar
PubMed Close
, and
Christiaan F. Mooij Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Search for other papers by Christiaan F. Mooij in
Google Scholar
PubMed Close

Introduction Graves’ disease (GD) is the most common cause of hyperthyroidism in both adults and children [ 1 ]. For patients with hyperthyroidism due to GD, there are 3 well-known and effective treatment options: antithyroid drugs (ATDs

Article Type:
Systematic Review
DOI:
https://doi.org/10.1159/000511345
Volume/Issue:
Volume 10: Issue 1
Open access
Georgios K. Markantes Division of Endocrinology – Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Search for other papers by Georgios K. Markantes in
Google Scholar
PubMed Close
,
Marina A. Michalaki Division of Endocrinology – Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Search for other papers by Marina A. Michalaki in
Google Scholar
PubMed Close
,
George A. Vagenakis Department of Pediatric Cardiology and Adult Congenital Heart Disease, Onassis Cardiac Surgery Center, Athens, Greece

Search for other papers by George A. Vagenakis in
Google Scholar
PubMed Close
,
Fotini N. Lamari Laboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, University of Patras, Patras, Greece

Search for other papers by Fotini N. Lamari in
Google Scholar
PubMed Close
,
Efthymia Pitsi Laboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, University of Patras, Patras, Greece

Search for other papers by Efthymia Pitsi in
Google Scholar
PubMed Close
,
Maria Eliopoulou Endocrinology Unit, Karamandanio Hospital, Patras, Greece

Search for other papers by Maria Eliopoulou in
Google Scholar
PubMed Close
,
Nicholas G. Beratis Department of Pediatrics, University of Patras Medical School, Patras, Greece

Search for other papers by Nicholas G. Beratis in
Google Scholar
PubMed Close
, and
Kostas B. Markou Division of Endocrinology – Department of Internal Medicine, University of Patras Medical School, Patras, Greece

Search for other papers by Kostas B. Markou in
Google Scholar
PubMed Close

Introduction Amiodarone-induced thyroid dysfunction, either hypothyroidism (AIH) or hyperthyroidism – thyrotoxicosis (AIT), affects up to 20% of amiodarone-treated patients [ 1 ]. Two types of AIT exist and they are characterized by distinct

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000500355
Volume/Issue:
Volume 8: Issue 4
Free access